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Original scientific paper
stroke are controversial due to degree of studies pro2,8-10 
and many contra11,12 that association. In this study we 
investigated a possible association between HPBI and 
acute stroke and the purpose was to determine whether 
HBPI is an indipendent risk factor for stroke, if there is a 
link between HBPI and severity of disease, find out is 
there relations between HBPI and established risk factors 
for stroke.
Material and Methods
In this prospective study were enrolled 82 patients con-
secutively admitted with acute stroke, but without known 
peptic ulcer disease or reciving therapy for H. pylori erad-
ication in the last year. All subjects had given informed 
consent to inclusion in the study and research was carried 
out according with principles of Declaration of Helsinki. 
Control group consists of healthy subjects and they were 
excluded if they had history of peptic ulcer disease, re-
ceived therapy for eradication H. pylori or received acid-
suppresive drugs in last 12 months.
A B S T R A C T
The aim of this investigation was to determine whether Helicobacter pylori infection (HBPI) is an independent risk 
factor for acute noncardioembolic stroke, and also if there is a link between HBPI and other established and well-known 
risk factors for stroke, as well, to find if there is link between HBPI and severity of disease. In this prospective single cen-
tre study where enrolled 82 patients with acute stroke and control group was consistented 93 healthy individuals. The 
results of this study showed no difference between H.pylori seropositivity distribution in the investigate and control group 
(25.8 vs. 34.8%), additionally, there was no significant difference on the severity of the disease. Furthermore there was no 
evident association between acute stroke and HBPI in the patientes with three and more risk factors, but we found sig-
nificant link between HBPI and carotid stenosis. Further studies are needed to clarify the possible causal relation between 
infection by this organism and stroke. It is necessary not only the elucidate of pathophysiology related to the association, 
but also to evaluate whether antibiotic treatment may result in clinical benefit of the patient.
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Introduction
Stroke is amnog the most frequent causes of death and 
persisting disability in the world1. Classical risk factors 
cannot fully explain the clinical and epidemiological fea-
tures of the disease2. There are several studies which 
showes that HBPI cause low grade infection which can 
lead to production vasoactive supstancies and can contrib-
ute to development of atherosclerosis and stroke3. Some 
mechanisms may play role in atherogenesis of HPBI: free 
radical formation and immune mediated mechanisms, 
direct influence on coagulation system. HPBI may cause 
prothrombotic status, could induce changes in coagulation 
with elevated serum levels of fibrinogen, prothrombin 
fragments, plasminogen-activating inhibitor-1 (PAI 1) and 
factor VII. Another possible mechanism linking HBPI and 
atherogenesis is lipid peroxidation due to an antioxidans 
loss or could be mediated by increasing cytokine levels4-6. 
There is potential that chronic bacterial infection may ag-
gravate pre-existing plaque by enhancing T-cell activation 
as well as other inflammatory responses that may par-
ticipate in the destabilization of the intimal cap resulting 
in plaque rupture, progression to acute ischemic syn-
dromes, and ultimate enlargment of the atherosclerotic 
plaque7. Results on the association betweeen HBPI and 
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All patients underwent cranial MSCT scaning, Duplex 
ultrasonography of the extracranial carotid arteries and 
transthoracic echocardiography to exclude patientis with 
cardioembolic stroke. Analyzed risk factors for stroke in-
cluded hypertension, diabetes, hyperlipidemia, obesity, 
gender and cigarette smoking. Carotid stenosis is the pos-
sible cause of 1/3 patients with ischemic stroke. Abnormal 
findings of Duplex ultrasonography of the extracranial 
carotid arteries were further subdivided into groups ac-
cording to the percent of stenosis. First degree of carotid 
stenosis (<50%), with middle stenosis (50-75%) and severe 
stenosis (>75%). Hypertension was considered in the pa-
tients with arterial pressure >140/90 mmHg, or were be-
ing treated with antihypertensive drugs or dietary modi-
fications. Diabetic patients were considered to have 
diabetes if they have had fasting glucose >6.4 mmol/L, 
HbA1c>6.0% or were taking insulin, hypoglicemic agents 
or dietary modification to control the disease. Hyperlipid-
emia was considered in patients with serum cholesterol 
levels >5.2 mmol/L or receiving lipid lowering agents. Obe-
sity status was defined followed by body mass index (BMI): 
subjects with BMI <24 were considered normal, BMI 
25–29 were considered overweight and BMI >30 were con-
sidered obese. Smoking as risk factor was not considered 
in patients who had stopped smoking >20 years ago or who 
were <30 years of age when they stopped smoking. All 
subjects (patients with AMI and control group) underwent 
an enzyme-linked Immulite (chemiluminescent) analyzer 
IgG serologic test for H. pylori diagnosis (Diagnostic Prod-
ucts Corp., Los Angeles, CA, USA). The test had a sensi-
tivity of 97% and a specificity of 98%.The severity of dis-
ease was present according to the National Institute of 
Health Stroke Scale (NIHSS). Statistical analysis was 
carried out by using SPSS software (Statistical Package 
for the Social Sciences, version 11,0, SPSS Inc., Chicago, 
IL, USA). For comparing differences between sets of re-
sults we used t–tests and for associations between vari-
ables correlation methods. Regression analysis was used 
for prediction of H. pylori seropositivity, χ² test was used 
to find out differences between frequency of risk factors. 
Results were shown by average values with standard de-
viations. A value of p < 0.05 was considered statistically 
significant.
Results
Investigate group was consisted of 83 patients with 
acute stroke consecutively admitted in stroke care unit. 
There was 32 men and 34 women, average age of 72.8 
years. 20 (30.3%) had haemorrhagic stroke and 46 (69.7%) 
ischemic stroke. 16 patients were excluded because of car-
dioembolic stroke. The control group consists of 93 healthy 
individuals. (Table 1)
There was 80.3% hypertonic patients in the investigate 
group, there was 39.4% diabetic patients. Dyslipidemia 
was present in the 56% patients. In the investigate group 
33.3% patients were overweight, there were 21.2% smok-
ing patients. On the carotid ultrasonography there were 
20.2% with normal findings, 31.8% with first degree of 
TABLE 1
DEMOGRAPHIC CHARACTERISTICS OF PATIENTS (N=66)
Characteristics No (%)
Sex
Male 32 (48.5)
Female 34 (51.5)
Age
Mean±SD — yr 72.8±9.6
ICV
Haemorrhagic 20 (30.3)
Ischemic 46 (69.7)
NIHSS*
Minor 8 (12.1)
Moderate 50 (75.8)
Severe 8 (12.1)
Carotide stenosis
No stenosis 14 (21.2)
First degree stenosis <50% 21 (31.8)
Mild stenosis 50-75% 24 (36.4)
Severe stenosis >75% 7 (10.6)
Hypertension
No 13 (19.7)
Yes 53 (80.3)
Smoking
No 52 (78.8)
Yes 14 (21.2)
Cholesterol
Normal 29 (43.9)
High 37 (56.1)
Diabetes
No 40 (60.6)
Yes 26 (39.4)
Obesity
No 44 (66.7)
Yes 22 (33.3)
Leukocytes
Normal 43 (65.2)
High 23 (34.8)
CRP
Normal 28 (42.4)
High 38 (57.6)
Fibrinogen
Normal 45 (68.2)
High 21 (31.8)
HBP test
Negative 43 (65.2)
Positive 23 (34.8)
*National Institutes of Health Stroke Scale
carotid stenosis (<50%), 36.4% with middle stenosis (50-
75%) and severe stenosis (>75%) 10.6% patientes. There 
was no significant differences between HBP seropositiv-
ity distribution in the investigate and control group (34.8% 
vs 25.8% Table 2), also there was no significant differ-
ences between men and women. (Table 2)
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χ2=0.759, df=1, p=0.3836 There was no significant dif-
ferences on the association of H. pylori infection with 
cigarette smoking.
Measurement of CRP, fibrinogn and leukocyte was 
performed in all stroke patients. There was no significant 
diference between group with HBP seropositivity versus 
group with no seropositivity.There was no significant as-
sociation between HBP seropositivity and acute stroke 
in the patients with 3 and more risk factors, but we found 
significant link between HBPI and carotid stenosis (Ta-
ble 8). In summary our study shows no association be-
tween HBPI and stroke.
There were no significant diferrences between men 
and women in distribution of hypertension, obesity, dia-
betes, hyperlipidaemia, cigarette smoking. There was no 
significant differences on the severity of the disease ac-
cording to the H. pylori seropositivity. Procalcitonin as a 
marker for infection was in normal levels in both patients 
and control group, independent of H. pylori seropositivity. 
There was no significant differences on the association of 
H. pylori infection with well known risk factors (hyperten-
sion, obesity, diabetes, hyperlipidaemia, cigarette smoking 
including gender) and we did not established HBPI as an 
independent risk factor for stroke (Tables 3-7). 
TABLE 2
DISTRIBUTION OF HBP IN THE INVESTIGATE AND CONTROL 
GROUP
Control Investigate  
Negative 69 43 112 (70.4%)
Positive 24 23 47 (29.6%)
 93 (58.5%)
66 
(41.5%) 159
χ2=1.113, df=1, p=0.2914 There was no significant differences between 
HBP seropositivity distribution in the investigate and control group.
TABLE 3
DISTRIBUTION OF HYPERTENSIVE PATIENTS ACCORDING 
INCIDENCE OF HBP
HBP negative HBP positive  
No 7 6 13 (19.7%)
Yes 36 17 53 (80.3%)
 43 (65.2%)
23 
(34.8%) 66 (100%)
χ2=0.397, df=1, p=0.5286 There was no significant differences on 
the association of H. pylori infection with hypertension.
TABLE 8
DISTRIBUTION OF PATIENTS WITH CAROTIDE STENOSIS 
ACCORDING INCIDENCE OF HBP
HBP positive HBP negative  
No stenosis 2 12 14 (21.2%)
First degree 
stenosis <50% 9 12 21 (31.8%)
Mild stenosis 
50-75% 12 12 24 (36.4%)
Severe stenosis 
>75% 0 7 7 (10.6%)
 23 (34.9%)
34 
(65.1%) 66 (100%)
χ2=9.371, df=3, p=0.0247 There were significant differences be-
tween HBP positive and HBP negative according the carotide steno-
sis. 
TABLE 4
DISTRIBUTION OF OBESITIVE PATIENTS ACCORDING 
INCIDENCE OF HBP
HBP negative HBP positive  
No 27 17 44 (66.7%)
Yes 16 6 22 (33.3%)
 43 (65.2%)
23 
(34.8%) 66 (100%)
χ2=0.409, df=1, p=0.5225 There was no significant differences on 
the association of H. pylori infection with obesity.
TABLE 5
DISTRIBUTION OF DIABETIC PATIENTS ACCORDING 
INCIDENCE OF HBP
HBP negative HBP positive  
No 26 14 40 (60.6%)
Yes 17 9 26 (39.4%)
 43 (65.2%)
23 
(34.8%) 66 (100%)
χ2=0,054, df=1, p=0,8612 There was no significant differences on 
the association of H. pylori infection with diabetes.
TABLE 6
DISTRIBUTION OF PATIENTS WITH HYPERLIPIDEMIC 
PATIENTS ACCORDING INCIDENCE OF HBP
HBP negative HBP positive  
Normal 19 10 29 (43.9%)
High 24 13 37 (56.1%)
 43 (65.2%)
23 
(34.8%) 66 (100%)
χ2=0.042, df=1, p=0.8376 There was no significant differences on 
the association of H. pylori infection with cholesterol.
TABLE 7
DISTRIBUTION OF CIGARETTE-SMOKING PATIENTS 
ACCORDING INCIDENCE OF HBP
HBP negative HBP positive  
Non-smoker 32 20 52 (78.8%)
Smoker 11 3 14 (21.2%)
 43 (65.2%)
23 
(34.8%) 66 (100%)
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Discussion
Cardiovascular diseases are important cause of mortal-
ity. Classical risk factors cannot fully explain epidemio-
logical variations of these disease. Helicobacter pylori are 
gram-negative bacteria which produce a chronic infection 
in humans associated with peptic ulcer disease, gastritis. 
H. pylori infection may increase risk for acute stroke 
through the changes in the lipid status with lower HDL 
cholesterol values and elevated serum trigliceride values, 
changes in the coagulation paremeters with elevated fi-
brinogen, prothrombin fragments, plasminogen-activating 
inhibitor 1 (PAI-1) and factor VII , increased concentrations 
of markers of inflammation as a tumor necrosis factor – α 
(TNF-α), interleukin-6 (IL-6), interleukin-8 (IL-8) and oth-
ers. J. Majka reported HPBI as an risk factor for stroke via 
an interaction of HP cytoxins or cytokines with atheroscle-
rotic plaques in carotic arteries. It has been noticed possible 
direct effect on the stability of the atherosclerotic plaque. 
Most studies suggested that HBPI might be associated with 
stroke due to an increased prevalence of this organism in 
patientes with stroke. The pathophysiological mechanism 
underlying this association seems likely to be chronic in-
flamatory response to bacterial infection13. Since 1994 sev-
eral studies have been performed on the correlation be-
tween HBPI and atherosclerosis. Despite all these studies 
there are still many controversies about the role of HBPI in 
stroke. Although most respective studies analyzed IgG an-
tibodies against H. pylori in patientes with acute stroke and 
find association between HBP serpositivity and stroke, find 
HBPI as an independent risk factor for stroke of athero-
thrombotic origin2,14. The results of Sawayama suggest that 
chronic HBPI may be a triggering factor that increases the 
risk of acute ischemic stroke. Some prospective studies 
founded the strongly relation between HBPI and major 
cerebrovascular risk factors particulary cigarette smoking, 
diabetes, hypertension. With respect to stroke a nested 
case-control study with 137 patientes and 137 control sub-
ject found a trend to an increased risk by positive HBPI in 
adult with lower socioeconomic status and vascular risk 
factors15. H. pylori infection and cerebrovascular disease 
are associatted with lower socioeconomic status and their 
frequency is higher with older age16. In our study we faund 
34.8% patients HBP seropositive patients with acute stroke 
vs. 25.8 seropositive healthy controls. There was not sig-
nificant statistical difference (p=0.29 ) between these 
groups which sugest that HBPI is not independent risk fac-
tor for acute stroke. In our study there was significantly 
lower incidence of HBPI in both patients and controls, par-
ticulary due to exclusion criteria of all participants with 
known gastric disease, or reciving therapy for gastric dis-
ease or eradication for H. pylori, particulary for better so-
cioeconomic conditions compare to postwar period in Croa-
tia in recent studies17. Age of patientes in investigate group 
is not the limitation of the present study according to the 
results of Biagi P. who found the same prevalence of HBPI 
in group of hospitalized geriatric patients as in yonger 
group.
Our study investigated the relation between HBPI and 
carotid stenosis and found significant association. One 
study in Argentina guided by F. Ameriso demonstrated 
the presence of the microorganism in carotid lesions but 
they where unable to speculate on the role of HBPI18. Pas-
ceri et al have demonstrated a higher prevalence of either 
H. pylori infection or Cag-A positive strains in 52% of the 
vascular disease patientes compared to 43% of controls. 
On the other site Sulewska A. found no DNA of HBP in 
atherosclerotis plaques, just like Stephen D. H. who re-
ported no evidence for physical localization of HBP in ca-
rotid atherosclerotic plaques19. Just like F. Ameriso et al 
Michael R. Preuch supported the hypothesis of an asso-
ciation between infection CaG A-positive HBP strains and 
acute stroke. According to same recent studies and com-
paring the results of our patientes we noticed possible 
direct effect HBPI on the stability of the atherosclerotic 
plaque. Our prospective study does not provide evidence 
of any strong association between the HBPI and stroke. 
Further studies are are required to reveal the role HBPI 
as an risk factor cerebrovascular disease and to confirm 
our findings.
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INFEKCIJA HELIBACTER PYLORI I AKUTNI MOŽDANI UDAR
S A Ž E T A K
Cilj ovog istraživanja je bio odrediti da li infekcija Helicobacter pylori predstavlja neovisan faktor rizika za moždani 
udar, odrediti da li postoji povezanost težine kliničke slike oboljelog od moždanog udara s infekcijom H. pylori. U ovu 
prospektivnu studiju provedenu u jednom centru uključena su 82 bolesnika s akutnim moždanim udarom i 93 zdrava 
ispitanika u kontrolnoj skupini. Rezulati studije nisu pokazali značajnu razliku u distribuciji infekcije H. pylori u ispi-
tanika i kontrolnoj skupini (34,8 vs. 25,8%) i nije nađena značajna razlika u težini bolesti prema seropozitivnosti na H. 
pylori. Značajna razlika uočena je između HBPI i oboljelih od stenoze karotide. Potrebne su veće multicentrične studije 
za određivanje precizne uloge H. pylori infekcije u nastanku akutnog moždanog udara.
